NIAID's Nasty Surprise

See allHide authors and affiliations

Science  09 May 2003:
Vol. 300, Issue 5621, pp. 877
DOI: 10.1126/science.300.5621.877b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The Bush Administration has ordered the National Institute of Allergy and Infectious Diseases (NIAID) to commit $233 million this fiscal year to buy millions of doses of a next-generation anthrax vaccine. This has caused NIAID, the second-largest branch of the National Institutes of Health, to put a hold on funds for an untold number of new grant applications until it reshuffles its budget, sending shock waves through the research community.